Justin Turner
Otolaryngology · Birmingham, ALNPI 1215076807
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $26,284 of the $33,578 with a category attached, or 78.3%. GSK accounts for 62.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $14,328 and has fallen 81.8% since, to $2,609 in 2025. Among otolaryngology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $746.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$21K
- Sanofi$6K
- Regeneron$3K
- Regeneron Healthcare Solutions, Inc.$2K
- Alk-abello, Inc$1K
- Optinose US, Inc.$178
- plus $400 from 8 others
Across 4 payments — averaging $17,623 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$70K
What the payments were for
- Consulting fees$26,28478%
- Speaking & faculty fees$4,01112%
- Travel & lodging$1,2024%
- Food & beverage$2,0826%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 16 | $21,002 |
| Sanofi | 3 | $5,930 |
| Regeneron | 2 | $2,860 |
| Regeneron Healthcare Solutions, Inc. | 10 | $1,809 |
| Alk-abello, Inc | 4 | $1,398 |
| Optinose US, Inc. | 2 | $178 |
| Intersect ENT, Inc. | 1 | $146 |
| Stryker | 1 | $73 |
| Smith+Nephew | 1 | $47 |
| Mauna Kea Technologies, Inc. | 1 | $39 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Acclarent, Inc | 1 | $24 |
| KARL Storz Endoscopy-america | 1 | $22 |
| AstraZeneca | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$33,578 in reported general payments places this provider in the 95th percentile of 155 otolaryngology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 28 | $426 |
| Azelastine Hcl | 23 | $376 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Birmingham
- Michael SillersBirmingham$53K
- Bradford WoodworthBirmingham$27K
- Patrick OwensBirmingham$26K
- Kirk WithrowBirmingham$22K
- Do-Yeon ChoBirmingham$19K
- Andrew FusonBirmingham$18K
- Benjamin GreeneBirmingham$15K
- William BarberBirmingham$13K
- Dennis PappasBirmingham$13K
- Ryan MarshallBirmingham$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.